We are thrilled to announce that Somnee, a category-defining neurotech wearable and sleep service developed by StimScience, has successfully raised $23 million in its latest funding round. This significant capital injection is a testament to the groundbreaking promise of our "closed-loop" diagnostic and therapeutic products, designed to improve neurological health and revolutionize the way individuals achieve restorative sleep. With the financial support of visionary investors like Khosla Ventures, we are poised to accelerate the commercialization of our breakthrough neuroscience and sleep research intellectual property.
At Somnee, we are committed to leveraging decades of pioneering work in sleep science and brain health to create life-changing solutions for individuals, athletes, researchers, clinicians, employers, and health plans alike. Our expert team, which includes leading scientists and founding researchers such as Dr. Matthew Walker, Dr. Rich Ivry, Dr. Robert Knight, and Dr. Ram Gurumoorthy, alongside professionals from tech giants like Fitbit, Google, Apple, and Samsung, is uniquely positioned to tackle the sleep health epidemic. Our technology not only helps people fall asleep faster but also enables them to stay asleep longer, thereby reducing disruptions and ensuring higher quality, restorative sleep.
As emphasized by our founding Chief Science Advisor, Dr. Matthew Walker, in his bestselling book “Why We Sleep,” prioritizing sleep is essential to resetting our brain and body health each day. This funding milestone empowers us to assemble a world-class team, refine our products, and scale our operations, ultimately advancing a holistic approach to sleep and neurological health. We are excited to continue our journey toward transforming lives and setting a new standard in neurotech and sleep service innovation.
